Product NDC: | 0781-3440 |
Proprietary Name: | Cosyntropin |
Non Proprietary Name: | Cosyntropin |
Active Ingredient(s): | .25 mg/mL & nbsp; Cosyntropin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3440 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202147 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120629 |
Package NDC: | 0781-3440-95 |
Package Description: | 10 VIAL in 1 CARTON (0781-3440-95) > 1 mL in 1 VIAL (0781-3440-71) |
NDC Code | 0781-3440-95 |
Proprietary Name | Cosyntropin |
Package Description | 10 VIAL in 1 CARTON (0781-3440-95) > 1 mL in 1 VIAL (0781-3440-71) |
Product NDC | 0781-3440 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cosyntropin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120629 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | COSYNTROPIN |
Strength Number | .25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenocorticotropic Hormone [Chemical/Ingredient],Adrenocorticotropic Hormone [EPC] |